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Abstract  
The APOE ɛ4 allele and the Met variant of the BDNF Val66Met polymorphism are 
associated with reduced cognitive function in older adults. The aim of this study was to 
examine the independent and interactional effect of the APOE ɛ4 allele and BDNF Val66Met 
polymorphism on cognitive function in a cohort of healthy older adults who had undertaken 
further university level education. Multiple group Latent Growth Curve Modelling revealed 
no change in cognitive function over time in APOE ɛ4-carriers or in BDNF Met-carriers, nor 
in carriers of both APOE-ɛ4 and BDNF-Met alleles. Further, the results indicate that allelic 
variation in either APOE or BDNF does not modify the beneficial effects of a university 
based education intervention on cognitive function over a four-year period following the 
intervention. 
Introduction (see Supplement 1 for extended Introduction) 
Carriers of the apolipoprotein (APOE) ɛ4 allele demonstrate poorer performance compared to 
non-carriers across a range of cognitive functions, including episodic memory, executive 
function  and general cognition (Wisdom, et al., 2011); with the cognitive decline in ɛ4-
carriers becoming more pronounced with age (Wisdom, et al., 2011). Similarly, brain derived 
neurotrophic factor (BDNF) is thought to contribute to variance in adult cognitive function, 
with several studies reporting that healthy older BDNF-Met carriers display reduced 
cognitive function relative to Val-homozygotes (Egan, et al., 2003).We examined the 
influence of the APOE ɛ4 allele and BDNF Met polymorphism on the longitudinally assessed 
cognitive performance of healthy older adults who have undertaken an education 
intervention. This intervention has been shown to result in improved cognitive reserve in this 
sample (Lenehan, et al., 2016).  
Methods (see Supplement 2 for extended Method) 
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A total of 444 healthy adults aged between 50 and 79 years were recruited from the 
Tasmanian Healthy Brain Project (THBP) participant pool (Summers, et al., 2013). The 
intervention group (n = 344) had completed a minimum of 12 months part-time or full-time 
university study comprising a minimum of two units at undergraduate or post graduate levels. 
The remaining 100 participants were a control reference group who had not undertaken any 
intervention. The project was approved by the Human Research Ethics Committee 
(Tasmania) Network and further details of the study protocol have been previously published 
(Summers, et al., 2013). All participants in the THBP completed a comprehensive testing 
battery (see Supplement 2; Summers, et al., 2013). DNA was extracted from saliva samples 
with APOE and BDNF genotype being determined using a one-step ARMS-PCR. 
Core Data (see Supplement 2 for extended description of Analyses) 
Multiple Group Latent Growth Curve Modelling (LGCM) using maximum likelihood 
estimation was used to compare group differences in APOE genotype (control non-ɛ4 carrier; 
control ɛ4-carrier; intervention non-ɛ4 carrier; and, intervention ɛ4-carrier), BDNF genotype 
(control Val-homozygote; control Met-carrier; intervention Val-homozygote; and 
intervention Met-carrier), and APOE/BDNF genotype (ɛ4/ Met, non- ɛ4/ Met, ɛ4/ Val, non- 
ɛ4/ Val)  in longitudinal performance on composite measures of episodic memory, working 
memory, executive function and language processing. For APOE (see Supplement 3), the 
intervention ε4 group displayed higher working memory performance at baseline compared 
to the control group non- ε4 carriers. In addition, there was a significant difference between 
the rate of change in language processing over time between the control non-ε4 group 
(decrease over time) and the intervention non-ε4 group (increase over time).  There were no 
significant APOE group differences in episodic memory or executive function over time. For 
BDNF (see Supplement 4) the control Met-carrier group displayed lower baseline episodic 
memory than the intervention Val-carrier group and both intervention groups (Val-
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homozygote and Met-carrier) displayed significantly higher linear slopes in language 
processing compared to the control Val-carrier groups. For the interactive effect of 
APOE/BDNF (see Supplement 5) no differences between groups on any of the cognitive 
domains were detected at baseline, nor over time.  
Discussion of data (see Supplement 1 for extended Conclusions) 
No significant differences in baseline score or linear rate of change over time to working 
memory, episodic memory, executive function or language processing capacity were found 
between: intervention group ɛ4-carriers and non-ɛ4 carriers or between control group ɛ4-
carriers and non-ɛ4 carriers (Supplement 1); between Val-homozygotes and Met-carriers or 
between control group Val-homozygotes and Met-carriers (Supplement 2); or between any 
combination of APOE/BDNF genotype (Supplement 3). Further, there was no evidence of a 
genotype specific enhanced benefit of education-based intervention on cognitive function, 
with no differences in the linear slope of the intervention subgroups (APOE or BDNF) across 
any of the four cognitive domains. These results suggest that in a group of healthy older 
adults the APOE and BDNF genotypes are unrelated to cognitive performance or to the four-
year trajectory of cognitive change.  
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